Proteomic-based investigations on the mode of action of the marine anticancer compound rhizochalinin

The marine triterpene glycoside frondoside A exhibits activity in vitro and in vivo in prostate cancer

(2016) Sergey A. Dyshlovoy et al.   INTERNATIONAL JOURNAL OF CANCER

Guanidine Alkaloids from the Marine Sponge Monanchora pulchra Show Cytotoxic Properties and Prevent EGF-Induced Neoplastic Transformation in Vitro

(2016) Sergey Dyshlovoy et al.   Marine Drugs

Anti-migratory activity of marine alkaloid monanchocidin A - proteomics-based discovery and confirmation

(2016) Sergey A. Dyshlovoy et al.   PROTEOMICS

Inhibition of BRAF and MEK in BRAF-mutant melanoma

(2015) Keiran S M Smalley et al.   LANCET

Marine alkaloid Monanchocidin a overcomes drug resistance by induction of autophagy and lysosomal membrane permeabilization

(2015) Sergey A. Dyshlovoy et al.   Oncotarget

Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration

(2015) Amelie Hailer et al.   Oncotarget

Tumor-suppressivemicroRNA-218inhibits cancer cell migration and invasion via targeting ofLASP1in prostate cancer

(2014) Rika Nishikawa et al.   CANCER SCIENCE

Targeting RAS–ERK signalling in cancer: promises and challenges

(2014) Ahmed A. Samatar et al.   NATURE REVIEWS DRUG DISCOVERY

Activity of aaptamine and two derivatives, demethyloxyaaptamine and isoaaptamine, in cisplatin-resistant germ cell cancer

(2013) Sergey A. Dyshlovoy et al.   Journal of Proteomics

Proteomic Profiling of Germ Cell Cancer Cells Treated with Aaptamine, a Marine Alkaloid with Antiproliferative Activity

(2012) Sergey A. Dyshlovoy et al.   JOURNAL OF PROTEOME RESEARCH

Mycalamide A Shows Cytotoxic Properties and Prevents EGF-Induced Neoplastic Transformation through Inhibition of Nuclear Factors

(2012) Sergey A. Dyshlovoy et al.   Marine Drugs

The complexity of prostate cancer: genomic alterations and heterogeneity

(2012) Lara K. Boyd et al.   Nature Reviews Urology

Compensatory Pathways Induced by MEK Inhibition Are Effective Drug Targets for Combination Therapy against Castration-Resistant Prostate Cancer

(2011) D. Gioeli et al.   MOLECULAR CANCER THERAPEUTICS

The adaptor protein CRK is a pro-apoptotic transducer of endoplasmic reticulum stress

(2011) Kathryn Austgen et al.   NATURE CELL BIOLOGY

Keratins in health and cancer: more than mere epithelial cell markers

(2010) V Karantza   ONCOGENE

Comparative Proteome, Transcriptome, and Genome Analysis of a Gonadal and an Extragonadal Germ Cell Tumor Cell Line

(2008) Stephanie Glaesener et al.   JOURNAL OF PROTEOME RESEARCH